clinical trial · NCT04783766
Safety, Tolerability and Pharmacokinetics Study of CK-3773274
Obstructive Hypertrophic CardiomyopathyHealthy Adult SubjectsCK-3773274Placebo
brief summary
The purposes of this study are to: 1. Learn about the safety of CK-3773274 after a single dose and multiple doses in Chinese healthy adult subjects. 2. Learn how healthy subjects tolerate CK-3773274 after a single dose and multiple doses. 3. Find out how much CK-3773274 is in the blood after a single dose and multiple doses. 4. Determine the effect of doses of CK-3773274 on the pumping function of the heart. 5. Evaluate the effect CYP2D6 genetic polymorphisms on how the body metabolizes CK-3773274.
started
Apr 10, 2021
primary completion
Aug 5, 2021
completion
Aug 5, 2021
last updated
Jan 24, 2025
official title
A Phase 1, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of CK-3773274 in Healthy Chinese Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol